Penserra Capital Management’s Immunomedics Inc IMMU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-3,758
Closed -$319K 1166
2020
Q3
$319K Buy
+3,758
New +$190K 0.01% 383

Penserra Capital Management's IMMU Position: Q4 2020 in Review

Penserra Capital Management sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 3,758 shares — an estimated $319K sold.

Penserra Capital Management first reported a position in IMMU in Q3 2020 and held it in 1 quarter. The position peaked at $319K in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

  • Penserra Capital Management reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
  • Penserra Capital Management sold 3,758 Immunomedics Inc shares in Q4 2020, an estimated $319K.
  • Penserra Capital Management first reported a position in Immunomedics Inc in Q3 2020 and held it in 1 quarter.
  • Penserra Capital Management's Immunomedics Inc position peaked at $319K in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Penserra Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.